JP2002508364A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002508364A5 JP2002508364A5 JP2000539004A JP2000539004A JP2002508364A5 JP 2002508364 A5 JP2002508364 A5 JP 2002508364A5 JP 2000539004 A JP2000539004 A JP 2000539004A JP 2000539004 A JP2000539004 A JP 2000539004A JP 2002508364 A5 JP2002508364 A5 JP 2002508364A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- cycloalkyl
- alkoxy
- alkylthio
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6979197P | 1997-12-16 | 1997-12-16 | |
| US6972297P | 1997-12-16 | 1997-12-16 | |
| US60/069,791 | 1997-12-16 | ||
| US60/069,722 | 1997-12-16 | ||
| US8958998P | 1998-06-17 | 1998-06-17 | |
| US60/089,589 | 1998-06-17 | ||
| PCT/US1998/026008 WO1999031077A1 (en) | 1997-12-16 | 1998-12-08 | Arylpiperazines having activity at the serotonin 1a receptor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008120430A Division JP2008266337A (ja) | 1997-12-16 | 2008-05-02 | セロトニン１ａ受容体に対して活性を有するアリールピペラジン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002508364A JP2002508364A (ja) | 2002-03-19 |
| JP2002508364A5 true JP2002508364A5 (cg-RX-API-DMAC10.html) | 2005-09-15 |
Family
ID=27371593
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000539004A Withdrawn JP2002508364A (ja) | 1997-12-16 | 1998-12-08 | セロトニン１ａ受容体に対して活性を有するアリールピペラジン |
| JP2008120430A Pending JP2008266337A (ja) | 1997-12-16 | 2008-05-02 | セロトニン１ａ受容体に対して活性を有するアリールピペラジン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008120430A Pending JP2008266337A (ja) | 1997-12-16 | 2008-05-02 | セロトニン１ａ受容体に対して活性を有するアリールピペラジン |
Country Status (32)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA66370C2 (en) * | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
| DK1225881T3 (da) | 1999-09-03 | 2006-06-12 | Apbi Holdings Llc | Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion |
| EP1286980A2 (en) * | 2000-03-24 | 2003-03-05 | Eli Lilly And Company | Enantioselective process for preparing arylated lactones and derivatives |
| US6713479B2 (en) * | 2001-03-02 | 2004-03-30 | Sepracor Inc. | Piperidine-piperazine ligands for neurotransmitter receptors |
| DE10161809A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen |
| DE10161644A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | N,N'-disubstituierte Piperazin-Verbindungen |
| DE10205721A1 (de) * | 2002-02-12 | 2003-08-21 | Biotronik Mess & Therapieg | Führungsdraht und implantierbare Elektrodenleitung |
| US20030189215A1 (en) | 2002-04-09 | 2003-10-09 | Jong-Lam Lee | Method of fabricating vertical structure leds |
| ITMI20021328A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Ind Chimica E Farma | Nuove piperazine 1,4 - disostituite |
| US7071197B2 (en) | 2002-06-14 | 2006-07-04 | Recordati S.A. | N,N-disubstituted diazocycloalkanes |
| ITMI20021327A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilpiperazine |
| ITMI20021329A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilammine sostituite |
| US20040072839A1 (en) * | 2002-06-14 | 2004-04-15 | Amedeo Leonardi | 1-Phenylalkylpiperazines |
| AU2003268361A1 (en) * | 2002-08-30 | 2004-03-19 | Watson Pharmaceuticals, Inc. | Drug delivery system for treating urinary incontinence |
| PL376789A1 (pl) * | 2002-12-12 | 2006-01-09 | Aventis Pharma S.A. | Pochodne aminoindazoli i ich zastosowanie jako inhibitorów kinazy |
| GB0317370D0 (en) * | 2003-07-24 | 2003-08-27 | Synaptics Uk Ltd | Magnetic calibration array |
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
| EP1791904B1 (en) * | 2004-09-24 | 2014-08-27 | University of Maryland, Baltimore | Method of treating organophosphorous poisoning |
| JP2009521472A (ja) * | 2005-12-22 | 2009-06-04 | シェーリング コーポレイション | 心肺手術の合併症の予防としてのトロンビンレセプターアンタゴニスト |
| US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
| BRPI0922770A2 (pt) * | 2008-12-01 | 2019-09-24 | Procter & Gamble | sistemas de perfume |
| BR112012010766A2 (pt) * | 2009-11-06 | 2015-10-06 | Aerpio Therapeutics Inc | composições e métodos de tratamento da colite e de outras doenças instestinais |
| ES2719427T3 (es) | 2010-12-08 | 2019-07-10 | Expression Pathology Inc | Análisis cuantitativo de formas truncadas de HER2 por la técnica SRM/MRM |
| CN110713442A (zh) * | 2018-07-11 | 2020-01-21 | 程先波 | 一种邻硝基苯甲醛的制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB230303A (cg-RX-API-DMAC10.html) * | 1900-01-01 | |||
| US1013907A (en) * | 1910-08-22 | 1912-01-09 | David M Neuberger | Engine. |
| GB1013907A (en) * | 1962-09-13 | 1965-12-22 | Ici Ltd | Alkene derivatives |
| BE637389A (cg-RX-API-DMAC10.html) | 1962-09-13 | |||
| GB8909209D0 (en) | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US5382583A (en) | 1989-04-22 | 1995-01-17 | John Wyeth & Brother, Limited | Piperazine derivatives |
| US5340812A (en) | 1989-04-22 | 1994-08-23 | John Wyeth & Brother, Limited | Piperazine derivatives |
| GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
| GB2248499A (en) | 1990-10-05 | 1992-04-08 | Richard Branson | Seismic data interpretation digitising scanner |
| MX9201991A (es) | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| TW224974B (cg-RX-API-DMAC10.html) | 1991-07-02 | 1994-06-11 | Hoffmann La Roche | |
| CN1036395C (zh) | 1992-03-19 | 1997-11-12 | 约翰韦恩兄弟有限公司 | 哌嗪衍生物的制备方法 |
| GB9306103D0 (en) | 1993-03-24 | 1993-05-12 | Wyeth John & Brother Ltd | Piperazine derivatives |
| JPH06293803A (ja) | 1993-11-26 | 1994-10-21 | Loctite Corp | 光硬化性組成物 |
| EP0661266A1 (en) | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
| US5614523A (en) * | 1995-01-17 | 1997-03-25 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| GB9514384D0 (en) * | 1995-07-13 | 1995-09-13 | American Home Prod | Medical treatment |
| UA66370C2 (en) * | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
| EP1286980A2 (en) * | 2000-03-24 | 2003-03-05 | Eli Lilly And Company | Enantioselective process for preparing arylated lactones and derivatives |
-
1998
- 1998-08-12 UA UA2000063507A patent/UA66370C2/uk unknown
- 1998-12-01 TW TW087119922A patent/TW520366B/zh not_active IP Right Cessation
- 1998-12-08 AU AU18083/99A patent/AU747040B2/en not_active Ceased
- 1998-12-08 PL PL98342170A patent/PL193428B1/pl not_active IP Right Cessation
- 1998-12-08 BR BR9814280-1A patent/BR9814280A/pt not_active Application Discontinuation
- 1998-12-08 KR KR10-2000-7006518A patent/KR100539651B1/ko not_active Expired - Fee Related
- 1998-12-08 NZ NZ505220A patent/NZ505220A/xx unknown
- 1998-12-08 CA CA002506802A patent/CA2506802A1/en not_active Abandoned
- 1998-12-08 EA EA200000659A patent/EA003703B1/ru not_active IP Right Cessation
- 1998-12-08 HU HU0004596A patent/HU226409B1/hu not_active IP Right Cessation
- 1998-12-08 ID IDW20001140A patent/ID26930A/id unknown
- 1998-12-08 TR TR2000/01727T patent/TR200001727T2/xx unknown
- 1998-12-08 CN CNB988135191A patent/CN1227241C/zh not_active Expired - Fee Related
- 1998-12-08 CA CA002315227A patent/CA2315227C/en not_active Expired - Fee Related
- 1998-12-08 IL IL13672398A patent/IL136723A0/xx not_active IP Right Cessation
- 1998-12-08 HR HR20000406A patent/HRP20000406B1/xx not_active IP Right Cessation
- 1998-12-08 CN CNB2005101041777A patent/CN100355714C/zh not_active Expired - Fee Related
- 1998-12-08 JP JP2000539004A patent/JP2002508364A/ja not_active Withdrawn
- 1998-12-08 WO PCT/US1998/026008 patent/WO1999031077A1/en not_active Ceased
- 1998-12-09 US US09/208,553 patent/US6239135B1/en not_active Expired - Fee Related
- 1998-12-11 CO CO98073712A patent/CO4980859A1/es unknown
- 1998-12-14 PT PT98310223T patent/PT924205E/pt unknown
- 1998-12-14 PE PE1998001214A patent/PE20000134A1/es not_active Application Discontinuation
- 1998-12-14 DE DE69830297T patent/DE69830297T2/de not_active Expired - Fee Related
- 1998-12-14 EP EP04078368A patent/EP1514559A1/en not_active Withdrawn
- 1998-12-14 ZA ZA9811473A patent/ZA9811473B/xx unknown
- 1998-12-14 ES ES98310223T patent/ES2244036T3/es not_active Expired - Lifetime
- 1998-12-14 AT AT98310223T patent/ATE296296T1/de not_active IP Right Cessation
- 1998-12-14 DK DK98310223T patent/DK0924205T3/da active
- 1998-12-14 MY MYPI98005637A patent/MY125868A/en unknown
- 1998-12-14 EG EG154098A patent/EG23983A/xx active
- 1998-12-14 EP EP98310223A patent/EP0924205B1/en not_active Expired - Lifetime
- 1998-12-15 AR ARP980106355A patent/AR017864A1/es unknown
- 1998-12-15 SV SV1998000148A patent/SV1998000148A/es not_active Application Discontinuation
-
2000
- 2000-06-12 IL IL136723A patent/IL136723A/en unknown
- 2000-06-15 NO NO20003082A patent/NO317098B1/no unknown
-
2001
- 2001-01-03 US US09/753,645 patent/US6358958B2/en not_active Expired - Fee Related
- 2001-12-18 US US10/022,045 patent/US6645967B2/en not_active Expired - Fee Related
- 2001-12-18 US US10/022,043 patent/US6660859B2/en not_active Expired - Fee Related
-
2002
- 2002-04-30 US US10/136,101 patent/US6514976B2/en not_active Expired - Fee Related
-
2003
- 2003-04-16 US US10/419,063 patent/US7001908B2/en not_active Expired - Fee Related
- 2003-07-02 US US10/613,798 patent/US6946579B2/en not_active Expired - Fee Related
-
2005
- 2005-07-19 US US11/184,522 patent/US20050282817A1/en not_active Abandoned
- 2005-09-13 US US11/225,541 patent/US7309702B2/en not_active Expired - Fee Related
-
2006
- 2006-03-02 IL IL174074A patent/IL174074A0/en unknown
-
2008
- 2008-05-02 JP JP2008120430A patent/JP2008266337A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002508364A5 (cg-RX-API-DMAC10.html) | ||
| RU2388750C2 (ru) | Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина | |
| US6436938B1 (en) | Combination treatment for depression | |
| US8513288B2 (en) | 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity | |
| JP2006504656A5 (cg-RX-API-DMAC10.html) | ||
| JP2008538741A (ja) | 鬱病の治療用及び／又は予防用の医薬組成物 | |
| WO2007093624A2 (en) | Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin | |
| FR2814678A1 (fr) | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite | |
| US7105504B2 (en) | Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease | |
| JP2007513957A5 (cg-RX-API-DMAC10.html) | ||
| JP2005529926A5 (cg-RX-API-DMAC10.html) | ||
| EP1641461A1 (fr) | Association d'un antagoniste ou agoniste inverse du recepteur h3 de l'histamine avec un anti-psychotique ou un antidepresseur et son utilisation pour preparer un medicament prevenant des effets indesirables de medicaments psychotropes | |
| ES2426008T3 (es) | Tratamiento de síntomas de la enfermedad de Parkinson con ligandos del receptor de histamina H3 de alquilaminas no imidazólicas | |
| SK16602001A3 (sk) | Nové farmaceutické kombinácie inhibítorov NOS | |
| CA2345406A1 (en) | Analgesic | |
| JP2018203774A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| RU2003101396A (ru) | Замещенные нитрированные катехолы, их применение в лечении некоторых расстройств центральной и периферической нервной системы и содержащие их фармацевтические композиции | |
| JP2001520988A (ja) | 疾病に関連する、または薬物が引き起こす運動異常症の治療法 | |
| KR20010099648A (ko) | 신규 조성물 | |
| JP2002501045A5 (cg-RX-API-DMAC10.html) | ||
| EP1299120A2 (en) | Compositions comprising a serotonin transporter inhibitor and a 5-ht1d antagonist | |
| JP2004509869A5 (cg-RX-API-DMAC10.html) | ||
| JP2009545573A (ja) | サレデュタントとおよびセロトニン再取込みの選択的阻害剤またはセロトニン／ノルエピネフリン再取込みの阻害剤とを組み合わせて含有する医薬組成物 | |
| JP2021031392A (ja) | 胸腰椎脊柱変形の治療薬 | |
| JP2021031393A (ja) | 首下がり症候群の治療薬 |